This report provides an overview of the US immunodiagnostics market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays.

      Table of Contents

      Business Environment
        1. Health Care Expenditures
        2. Cost Consciousness
        3. Industry Consolidation
        4. Managed Care
        5. Hospitals
        6. Admissions
        7. Length of Stay
        8. Industry Diversification
        9. Physician Demographics
      10. Population Aging
                    a. Chronic Illness
                    b. Disease Incidence
                    c. Susceptibility to Iatrogenesis
                    d. Multiple Illness Cases
      11. Laboratory Regulations

      Market Structure
        1. Centralized Testing
                    a. Hospitals
                    b. Commercial/Private Laboratories
        2. Decentralized Testing
                    a. Physician Offices/Group Practices
                    b. Point-of-Care Testing
                    c. Home/Self Testing
                    d. Other Decentralized Testing Locations

      Market Size, Growth, Major Suppliers'
      Instrument and Reagent Sales and Market Shares

                     List of Tables

      Clinical Chemistry and Immunodiagnostic
      Volume Forecasts By Test Category

      Clinical Chemistry and Immunodiagnostic 
      Reagent Sales Forecasts By Test Category

      Clinical Chemistry and Immunodiagnostic
      Instrument Sales Forecasts By Analyzer Type

      Estimated Sales and Market Shares of Major Suppliers 
      Of Clinical Chemistry Instruments and Reagents

      Estimated Sales and Major Shares of Major Suppliers 
      Of Immunodiagnostic Instruments and Reagents

      Contains 35 pages and 5 tables